Impaired Fasting Glucose & 8-Iso-Prostaglandin F2α in Diabetes Disease Progression

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 33

Abstract

Aims: The objective of the present study was to evaluate the changes of 8-isoprostaglandin F2α and other markers of oxidative stress with impaired fasting glucose when compared to non-diabetic control participants. Methodology: This is a cross-sectional study, conducted at Charles Sturt University, Albury, NSW, Australia and included 428 participants (female: male, 247:181) participants attending the Diabetes Complications Clinic in the School of Community Health for the period between January 2011 to October 2012. Results: Urinary 8-isoprostaglandin F2α was significantly greater in the impaired fasting glucose group (1.4±1.3ng/ml) compared to control group (0.68±0.5ng/ml, P= .05). The increase in urinary 8-isoprostaglandin F2α was associated with a significant elevation in serum total cholesterol (4.7±1.1mol/L, P= .04) and a significant reduction in high density lipoprotein cholesterol (1.4±0.4mmol/L, P= .02) in the impaired fasting glucose group compared to the control group. A significant negative correlation was noted between urinary 8-isoprostaglandin F2α and high-density lipoprotein cholesterol among all the participants included in this study (P= .05). Conclusions: The current study proves the importance of measuring markers of oxidative stress, expressed by urinary 8-isoprostaglandin F2α and serum lipids in managing cases of impaired fasting glucose and suggests a useful biomarker for assessing disease progression and/or remission, especially in the prediabetic state.

Authors and Affiliations

Herbert F. Jelinek, Dina A. Jamil, Hayder A. Al-Aubaidy

Keywords

Related Articles

Sulfasalazine Improves Insulin Resistance and Endothelial Dysfunction in Metabolic Syndrome Patients

Aim: Metabolic syndrome (MetS) and all its components are independently characterized by the presence of low-grade chronic inflammation. The study aimed at controlling inflammation using sulfasalazine 500mg, once a day t...

Attitude and Perception to Tattoos and Scarified Skin Marks in Makurdi, North Central Nigeria

Aim: Tattoo art which has been practiced all over the world for centuries is undergoing a revolution. Some people like it, others don’t. The aim of the study was to estimate the prevalence of tattooing among students and...

Full Mouth Rehabilitation in a Patient with Amelogenesis Imperfecta: Treatment for Aesthetic and Functional Improvement

Introduction: Amelogenesis imperfecta (AI) is a dental anomaly that causes defects in enamel with no evident association of systemic disease. Presentation of Case: This clinical report describes the oral rehabilitation o...

Does Circadian Preference Determine Risk for Developing Alcohol Use Disorder amongst Undergraduate and Pre-University Students? A Cross-Sectional Study

Aims: To determine the relationship between circadian preference and risk for developing alcohol use disorder among medical students and pre-university students. Study Design: An analytical cross sectional study was con...

Etiopathogenesis and Stem Cell Treatment Outcomes in Avascular Necrosis of the Femoral Head: A Review of 50 Cases

Background and Aim: Avascular necrosis (AVN) is a progressive condition characterized by a vascular insult to the bone, which can lead to collapse of the bone and subsequent degenerative changes. Vascular impairment that...

Download PDF file
  • EP ID EP348741
  • DOI 10.9734/BJMMR/2014/11147
  • Views 91
  • Downloads 0

How To Cite

Herbert F. Jelinek, Dina A. Jamil, Hayder A. Al-Aubaidy (2014). Impaired Fasting Glucose & 8-Iso-Prostaglandin F2α in Diabetes Disease Progression. Journal of Advances in Medicine and Medical Research, 4(33), 5229-5237. https://europub.co.uk./articles/-A-348741